Update shared on23 Sep 2025
Fair value Decreased 7.25%The consensus analyst price target for Regis Healthcare has been revised down from A$8.61 to A$7.98, primarily reflecting weaker profitability as net profit margin declined and valuation multiples edged higher.
What's in the News
- Regis Healthcare announced a fully franked ordinary dividend of AUD 0.0813 per share for the six months ended June 30, 2025.
Valuation Changes
Summary of Valuation Changes for Regis Healthcare
- The Consensus Analyst Price Target has fallen from A$8.61 to A$7.98.
- The Net Profit Margin for Regis Healthcare has significantly fallen from 6.47% to 5.75%.
- The Future P/E for Regis Healthcare has risen slightly from 31.59x to 32.72x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.